Zimmer Biomet Holdings Stock Price To Sales
| ZIM Stock | EUR 101.45 0.10 0.1% |
Zimmer Biomet Holdings fundamentals help investors to digest information that contributes to Zimmer Biomet's financial success or failures. It also enables traders to predict the movement of Zimmer Stock. The fundamental analysis module provides a way to measure Zimmer Biomet's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Zimmer Biomet stock.
Zimmer |
Zimmer Biomet Holdings Company Price To Sales Analysis
Zimmer Biomet's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Zimmer Biomet Price To Sales | 3.27 X |
Most of Zimmer Biomet's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Zimmer Biomet Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Based on the latest financial disclosure, Zimmer Biomet Holdings has a Price To Sales of 3.2739 times. This is 84.7% lower than that of the Healthcare sector and 31.51% lower than that of the Medical Devices industry. The price to sales for all Germany stocks is 71.33% higher than that of the company.
Zimmer Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Zimmer Biomet's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Zimmer Biomet could also be used in its relative valuation, which is a method of valuing Zimmer Biomet by comparing valuation metrics of similar companies.Zimmer Biomet is currently under evaluation in price to sales category among its peers.
Zimmer Fundamentals
| Return On Equity | 0.0236 | |||
| Return On Asset | 0.0371 | |||
| Profit Margin | 0.03 % | |||
| Operating Margin | 0.19 % | |||
| Current Valuation | 29.79 B | |||
| Shares Outstanding | 210.06 M | |||
| Shares Owned By Institutions | 90.95 % | |||
| Price To Earning | 10.60 X | |||
| Price To Book | 2.15 X | |||
| Price To Sales | 3.27 X | |||
| Revenue | 6.94 B | |||
| Gross Profit | 4.92 B | |||
| EBITDA | 1.49 B | |||
| Net Income | 231.4 M | |||
| Cash And Equivalents | 403.1 M | |||
| Cash Per Share | 1.97 X | |||
| Total Debt | 5.32 B | |||
| Debt To Equity | 74.70 % | |||
| Current Ratio | 1.19 X | |||
| Book Value Per Share | 57.51 X | |||
| Cash Flow From Operations | 1.28 B | |||
| Earnings Per Share | 1.30 X | |||
| Price To Earnings To Growth | 1.06 X | |||
| Target Price | 188.04 | |||
| Number Of Employees | 18 K | |||
| Beta | 1.02 | |||
| Market Capitalization | 24.63 B | |||
| Total Asset | 21.07 B | |||
| Z Score | 2.4 | |||
| Annual Yield | 0.01 % | |||
| Five Year Return | 0.72 % | |||
| Net Asset | 21.07 B | |||
| Last Dividend Paid | 0.96 |
About Zimmer Biomet Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Zimmer Biomet Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Zimmer Biomet using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Zimmer Biomet Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Zimmer Stock
When determining whether Zimmer Biomet Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zimmer Biomet's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zimmer Biomet Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zimmer Biomet Holdings Stock:Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zimmer Biomet Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.